Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 22, 2010
Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP)Ingelise Jensen, Jesper Carl, Bente Lund, et al.Acta Radiologica (Stockholm, Sweden : 1987)|December 20, 2014
Presurgical functional magnetic resonance imaging in patients with brain tumorsSøren Ravn, Mats Holmberg, Preben Sørensen, et al.Acta Oncologica (Stockholm, Sweden)|August 29, 2013
Differences in supratentorial white matter diffusion after radiotherapy--new biomarker of normal brain tissue damage?Søren Ravn, Mats Holmberg, Preben Sørensen, et al.Medical Physics|February 7, 2007
Automated detection of a prostate Ni-Ti stent in electronic portal imagesJesper Carl, Henning Nielsen, Jane Nielsen, et al.Acta Oncologica (Stockholm, Sweden)|September 7, 2013
The use of an active appearance model for automated prostate segmentation in magnetic resonanceAnne Sofie Korsager, Ulrik Landberg Stephansen, Jesper Carl, et al.Acta Oncologica (Stockholm, Sweden)|September 14, 2010
Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beamsRochus Herrmann, Jesper Carl, Oliver Jäkel, et al.Journal of Applied Clinical Medical Physics|February 4, 2019
Assessment of prostate cancer prognostic Gleason grade group using zonal-specific features extracted from biparametric MRI using a KNN classifierCarina Jensen, Jesper Carl, Lars Boesen, et al.Radiation Oncology (London, England)|January 12, 2019
Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO)Jesper Carl, Dirk Rades, Claudia Doemer, et al.Acta Oncologica (Stockholm, Sweden)|July 12, 2008
A new fiducial marker for Image-guided radiotherapy of prostate cancer: clinical experienceJesper Carl, Jane Nielsen, Mats Holmberg, et al.Acta Oncologica (Stockholm, Sweden)|December 23, 2010
Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancerJesper Carl, Jane Nielsen, Mats Holmberg, et al.Pageof 3